Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-02-22 @ 2:58 AM
Study NCT ID:
NCT00431067
Status:
COMPLETED
Last Update Posted:
2014-06-09
First Post:
2007-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-02-02
First Submit QC Date:
None
Study First Post Date:
2007-02-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-08
Results First Submit QC Date:
None
Results First Post Date:
2013-12-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-03
Last Update Post Date:
2014-06-09
Last Update Post Date Type:
ESTIMATED